aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
Rong Fan(Kunming Institute of Botany), Jinlin Hou(Southern Medical University), George Ν. Dalekos(University Hospital of Larissa), Junqi Niu(Jilin University), Anuj Gaggar(Gilead Sciences (United States)), Indra Neil Guha(Nottingham University Hospitals NHS Trust), Vithika Suri(Gilead Sciences (United States)), Yongpeng Chen(Guangxi University of Science and Technology), Hidenori Toyoda(Ogaki Municipal Hospital), Eleanor Barnes(Oxford Health NHS Foundation Trust), George Papatheodoridis(National and Kapodistrian University of Athens), Jian Sun(Nanfang Hospital), Ramazan Idılman(Ankara University), José Luís Calleja(Hospital Universitario Puerta de Hierro Majadahonda), Sharon Hutchinson(Glasgow Caledonian University), Philip J. Johnson(Prince of Wales Hospital), Harry L.A. Janssen(Erasmus MC), Takashi Kumada(Gifu Kyoritsu University), Vana Sypsa(National and Kapodistrian University of Athens), Jianqi Lian(Air Force Medical University), John F. Flaherty(Gilead Sciences (United States)), Marı́a Buti(Vall d'Hebron Hospital Universitari), Lanjia Lin(Gilead Sciences (United States)), Shuyuan Mo(Gilead Sciences (United States)), Hamish Innes(Glasgow Caledonian University), Xiaoguang Dou(China Medical University), Peter Hayes(Centre for Inflammation Research), Qing Xie(Ruijin Hospital), William L. Irving(University of Nottingham), Thomas Berg(Leipzig University of Applied Sciences), Yuanping Zhou(Guangdong Medical College), Lai Wei(Tongji University), Longfeng Zhao(Shanxi Medical University), Zhengang Zhang(Vanguard University), Lei Shi(Unknown), Xiaoping Tang(Guangzhou Eighth People's Hospital), Satoshi Yasuda(Ogaki Municipal Hospital), Chaonan Zhu, Pietro Lampertico(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Stephen T. Barclay(Glasgow Royal Infirmary), Yabing Guo(Nanfang Hospital), Jidong Jia(National Clinical Research Center for Digestive Diseases)
Cited by 346
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
|Nature Immunology|2020|1.4k
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
|Liver International|2015|1.3k